STEPHANIE HUMBERT: Open Payments
NPI 1356022560 · WATERLOO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,009 in 50 payments from 10 companies in 2025. Trend: 2023 $293 · 2024 $1,766 · 2025 $1,009
Food & beverage: $1,009
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $308 |
| PFIZER INC. | 14 | $235 |
| Exact Sciences Corporation | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Lilly USA, LLC | 3 | $61 |
| Amgen Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
Products named: ELIQUIS, Rybelsus, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, PREVNAR 20, CAPLYTA, FARXIGA.
Industry payments across NY — which companies pay providers there.
